Aesculap, a B. Braun Company Director Medical Scientific Affairs shares insights on the three-year digital transformation journey to unify and standardize global clinical management.
Hear how Aesculap, a B. Braun company, shares a unified and standardized global clinical operation to drive efficiency, speed trials, and support growth.
Panelists:
Marius Selig
Medical Director Scientific Affairs
Aesculap, a B. Braun Company
Marius Selig graduated in clinical research at the University for Continuing Education Krems, Austria and has a further background in international business. Since 2016 he has been working in various functions in the Medical Scientific Affairs department of Aesculap. Over the years, he acquired broad expertise in project management, clinical research and cross-divisional collaboration. In his current function as Director Medical Scientific Affairs, he is responsible for the management of clinical studies and clinical evaluations for a major part of the products at the B. Braun division Aesculap.
Stéphanie Flipo
Director Clinical Strategy, MedTech EU
Veeva MedTech
Stéphanie Flipo has a master’s degree in nutritional sciences from the University of Bonn, Germany, and Toronto, Canada. Stéphanie has over 18 years of clinical research experience in the medical device and pharmaceutical industries, holding various clinical positions at ClinResearch (now ICON) and Sirtex, including project management and clinical strategy development. Stéphanie joined Veeva in 2021 and is leading the clinical strategy for MedTech in Europe.